Symproic
Chemical Name | naldemedine |
Dosage Form | Tablet (oral; 0.2 mg) |
Drug Class | Receptor antagonists |
System | Digestive |
Company | BioDelivery Sciences International Inc. |
Approval Year | 2017 |
Indication
- To treat opioid-induced constipations in adults with chronic non-cancer pain.